These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21246091)

  • 1. Comparative analysis of tissue availability for afobazole and compound M-11.
    Viglinskaya AO; Bastrygin DV; Kolyvanov GB; Litvin AA; Zherdev VP; Mozhaeva TY
    Bull Exp Biol Med; 2010 Sep; 149(3):318-9. PubMed ID: 21246091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of afobazole metabolite (M-11) in rats].
    Bastrygin DV; Viglinskaia AO; Kolyvanov GB; Litvin AA; Bochkov PO; Mozhaeva TIa; Zherdev VP
    Eksp Klin Farmakol; 2011; 74(7):22-6. PubMed ID: 21894764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue availability of afobazole and its major metabolites in rats.
    Viglinskaya AO; Kolyvanov GB; Litvin AA; Kravtsova OY; Zherdev VP; Seredenin SB
    Bull Exp Biol Med; 2007 May; 143(5):593-4. PubMed ID: 18239776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion of afobazole and its metabolites with urine and feces in rats.
    Viglinskaya AO; Kolyvanov GB; Litvin AA; Zherdev VP; Seredenin SB
    Bull Exp Biol Med; 2008 Apr; 145(4):440-2. PubMed ID: 19110588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of afobazole in rats].
    Seredenin SB; Viglinskaia AO; Kolyvanov GB; Litvin AA; Kravtsova OIu; Zherdev VP
    Eksp Klin Farmakol; 2007; 70(2):59-64. PubMed ID: 17523455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of compound M-11 and its metabolites with urine and feces in rats.
    Bastrygin DV; Viglinskaya AO; Kolyvanov GB; Litvin AA; Bochkov PO; Mozhaeva TY; Zherdev VP
    Bull Exp Biol Med; 2012 Sep; 153(5):707-9. PubMed ID: 23113264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Afobazole metabolism in rats].
    Seredenin SB; Viglinskaia AO; Mozhaeva TIa; Kolyvanov GB; Litvin AA; Avdiunina NI; Savel'ev VL; Zgerdev VP
    Eksp Klin Farmakol; 2008; 71(2):50-2. PubMed ID: 18488909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Model study of afobazole distribution in pregnant and lactating female rats and infant rat pups].
    Shreder OV; Kolyvanov GB; Litvin AA; Bastrygin DV; Shreder ED; Solomina AS; Viglinskaia AO; Zabrodina VV; Zherdev VP; Durnev AD; Seredenin SB
    Eksp Klin Farmakol; 2010 Aug; 73(8):17-20. PubMed ID: 20919552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic evaluation of a new prolonged dosage form of afobazole in comparison to commercially available tablets].
    Bochkov PO; Litvin AA; Kolyvanov GB; Zherdev VP; Blynskaia EV; Grushevskaia LN; Illarionov AA
    Eksp Klin Farmakol; 2013; 76(11):33-5. PubMed ID: 24555231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of afobazole on rats with bilateral local photothrombosis of vessels in the prefrontal cortex.
    Seredenin SB; Romanova GA; Shakova FM
    Bull Exp Biol Med; 2008 Feb; 145(2):207-9. PubMed ID: 19023970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetic evaluation of afobazole pharmaceutical composition with modified release].
    Bochkov PO; Litvin AA; Kolyvanov GB; Viglinskaya AO; Zherdev VP; Blynskaya EV; Alekseev KV
    Eksp Klin Farmakol; 2015; 78(3):27-9. PubMed ID: 26036008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vivo study of the pharmacokinetic interaction of afobazole and losartan (cytochrome CYP2C9 substrate)].
    Gribakina OG; Kolyvanov GB; Litvin AA; Zherdev VP; Seredin SB
    Eksp Klin Farmakol; 2013; 76(3):35-7. PubMed ID: 23767102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of afobazole on brain-ischemia-induced anxiety in rats].
    Seredenin SB; Akopian VP; Balasanian MG; Topchian AV
    Eksp Klin Farmakol; 2006; 69(2):3-5. PubMed ID: 16845930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral, intraperitoneal and intravenous pharmacokinetics of deramciclane and its N-desmethyl metabolite in the rat.
    Nemes KB; Abermann M; Bojti E; Grézal G; Al-Behaisi S; Klebovich I
    J Pharm Pharmacol; 2000 Jan; 52(1):47-51. PubMed ID: 10716602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroreceptor mechanisms of the afobazole effect].
    Seredenin SB; Voronin MV
    Eksp Klin Farmakol; 2009; 72(1):3-11. PubMed ID: 19334502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of afobazole on cognitive behavior of the offspring of rats exposed to tobacco smoke during gestation period.
    Shreder OV; Solomina AS; Tsorin IB; Trofimov SS; Durnev AD; Seredenin SB
    Bull Exp Biol Med; 2011 May; 151(1):41-6. PubMed ID: 22442799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimutagenic and antiteratogenic properties of afobazole].
    Durnev AD; Zhanataev AK; Shreder OV; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(1):46-51. PubMed ID: 19334511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of pharmacokinetic interaction of aphobazole with CYP1A2 drug-substrate in experiments].
    Novitskaia IaG; Litvin AA; Viglinskaia AO; Zherdev VP
    Eksp Klin Farmakol; 2013; 76(6):30-3. PubMed ID: 24003488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoprotective Effect of Afobazole and Its Main Metabolite M-11.
    Kadnikov IA; Voronin MV; Seredenin SB
    Bull Exp Biol Med; 2015 May; 159(1):44-7. PubMed ID: 26033588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [EVALUATION OF THE PHARMACOKINETIC INTERACTION OF AFOBAZOLE WITH CYP2C9 ENZYME DRUG SUBSTRATE OF CYTOCHROME P450].
    Gribakina OG; Kolyvanov GB; Litvin AA; Smirnov VV; Shevchenko RV; Zherdev VP
    Eksp Klin Farmakol; 2015; 78(12):18-22. PubMed ID: 27051923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.